HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Endophthalmitis (Ophthalmia)

Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
Also Known As:
Ophthalmia; Infectious Endophthalmitis; Endophthalmitides; Endophthalmitides, Infectious; Endophthalmitis, Infectious; Infectious Endophthalmitides; Ophthalmias
Networked: 2842 relevant articles (206 outcomes, 330 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Cataract (Cataracts)
2. Keratitis
3. Infection
4. Wounds and Injuries (Trauma)
5. Inflammation

Experts

1. Flynn, Harry W: 81 articles (01/2016 - 04/2002)
2. Miller, Darlene: 42 articles (02/2015 - 04/2002)
3. Scott, Ingrid U: 33 articles (03/2014 - 04/2002)
4. Pathengay, Avinash: 22 articles (01/2015 - 05/2006)
5. Mieler, William F: 19 articles (01/2016 - 01/2002)
6. Das, Taraprasad: 17 articles (01/2016 - 01/2002)
7. Sharma, Savitri: 17 articles (11/2015 - 01/2002)
8. Smiddy, William E: 17 articles (06/2015 - 01/2004)
9. Murray, Timothy G: 14 articles (01/2014 - 02/2003)
10. Hariprasad, Seenu M: 13 articles (01/2016 - 01/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Endophthalmitis:
1. Anti-Bacterial Agents (Antibiotics)IBA
2. VancomycinFDA LinkGeneric
3. Fluconazole (Zonal)FDA LinkGeneric
4. Amphotericin B (Amphotericin)FDA LinkGeneric
5. moxifloxacin (Avelox)FDA Link
08/01/2010 - "H2O2 exposure did not increase cellular toxicity Vigamox did not show significant toxicity on primary RPEs, TMCs, LECs, CECs, or human corneal endothelium at concentrations up to 150 microg/ml. The MIC90 of moxifloxacin for pathogens commonly encountered in endophthalmitis is known to be in the range of 0.25-2.5 microg/ml. Therefore, intracameral use of Vigamox at concentrations up to 150 microg/ml may be safe and effective for preventing endophthalmitis after intraocular surgery."
03/01/2008 - "No significant toxicity of moxifloxacin was seen on primary RPE cells, ARPE19 cells, or ONHA cells at concentrations up to 150 microg/mL. Intravitreal use of moxifloxacin up to this concentration may be safe and effective for the treatment of endophthalmitis."
09/01/2005 - "Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model."
08/01/2010 - "[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? "
06/01/2009 - "This study showed no significant toxicity for moxifloxacin on CEC, TMC, RPE cells, or human corneal endothelium for concentrations up to 150 microg/mL. The minimum inhibitory concentration of moxifloxacin to inhibit 90% of pathogens commonly encountered in endophthalmitis is known to be in the range of 0.25-2.5 microg/mL. Therefore, prophylactic intracameral use of moxifloxacin at concentrations up to 150 microg/mL may be safely used to prevent endophthalmitis after intraocular surgery."
6. voriconazole (Vfend)FDA LinkGeneric
7. Cefuroxime (Zinacef)FDA LinkGeneric
8. Ofloxacin (Levofloxacin)FDA LinkGeneric
9. Dexamethasone (Maxidex)FDA LinkGeneric
10. Povidone-Iodine (Betadine)FDA LinkGeneric

Therapies and Procedures

1. Vitrectomy
2. Intravitreal Injections
3. Antibiotic Prophylaxis
4. Intraocular Lenses (Intraocular Lens)
5. Phacoemulsification